The largest database of trusted experimental protocols

Cd15 mma

Manufactured by BD
Sourced in United States, Japan

The CD15/MMA is a laboratory equipment product designed for cellular analysis. It serves as a tool for the identification and enumeration of CD15-positive cells in biological samples. The product's core function is to provide accurate and reliable data on the presence and distribution of CD15-expressing cells, which can be useful in various research and diagnostic applications.

Automatically generated - may contain errors

2 protocols using cd15 mma

1

Immunohistochemical Analysis of EBV-Related Lymphomas

Check if the same lab product or an alternative is used in the 5 most similar protocols
Tissue samples were fixed in 10% formalin and embedded in paraffin (FFPE), followed by staining of 3 μm-thick sections with hematoxylin and eosin. The immunohistochemistry for 12 EBVMCU cases was performed by an autoimmunostainer using BenchMark ULTRA (Ventana, Oro Valley, AZ, USA) and Leica Bond-III (Leica Biosystems, Wetzlar, Germany). Monoclonal antibodies were as follows; anti-CD3/LN10, CD20/L26, CD10/56C6, BCL6/LN22, EBNA2/PE2 (Novocastra Laboratories, Newcastle, UK), CD30/Ber-H2, MUM-1/MUM1p, LMP1/C.S1-4 (DAKO, Santa Fe, CA, USA), CD15/MMA (Becton Dickinson and Company, NJ, USA), PD-L1/E1J2J (Cell Signaling Technology, MA, USA), PD-L1/SP142 (Roche, Basel, CHE). EBV infection was evaluated by in situ hybridizations for EBV-encoded small RNA (EBER) oligonucleotide probe (PB0589, Leica Biosystems) on FFPE sections using Leica Bond-III.
+ Open protocol
+ Expand
2

Immunohistochemical Analysis of Hematological Malignancies

Check if the same lab product or an alternative is used in the 5 most similar protocols
The biopsied materials were fixed in 10% neutralbuffered formalin, embedded in paraffin, cut into 4-mm-thick sections, and stained with hematoxylin and eosin for routine histopathological evaluation. All specimens were diagnosed by 2 pathologists (AMM and HT) according to the World Health Organization Classification of Tumours of Haematopoietic and Lymphoid Tissues published in 2008. 12 Immunohistochemical analysis of formalin-fixed, paraffinembedded tissues was performed by standard procedures. Antibodies against the following antigens were used: CD3 (PS1, 1:25; Novocastra, Newcastle, UK), CD5 (4C7, 1:100; Novocastra), CD10 (56C6, 1:100; Novocastra), CD15 (MMA, 1:100; Becton Dickinson, Tokyo, Japan), CD20 (L26, 1:200; Dako, Glostrup, Denmark), CD23 (1B12, 1:100; Novocastra), CD30 (Ber-H2, 1:100; Dako), CD56 (1B6, 1: 100; Novocastra), CD138 (MI15, ready for use; Leica, Newcastle, UK), ALK (ALK1, 1:200; Dako), Bcl-2 (124, 1: 100; Dako), cyclin D1 (SP4, ready for use; Nichirei, Tokyo, Japan), granzyme B (GrB-7, 1:200; Dako), TIA-1 (26gA10F5, 1:1,000; Immunotech, Marseille, France), TdT (poly, 1:20; Dako), k (poly, 1:20,000; Dako), and l (poly, 1: 40,000; Dako). In situ hybridization with an EBV-encoded small nuclear early region (EBER)-1 probe (Dako) was performed to detect possible EBV infection.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!